Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group
about
Antiproteases for acute pancreatitisHereditary pancreatitis: new insights into acute and chronic pancreatitisCCK independently activates intracellular trypsinogen and NF-kappaB in rat pancreatic acinar cells.Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.Caerulein-induced intracellular pancreatic zymogen activation is dependent on calcineurin.Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitisEarly ERCP is an essential part of the management of all cases of acute pancreatitis.Alcohols enhance caerulein-induced zymogen activation in pancreatic acinar cellsZymogen activation in a reconstituted pancreatic acinar cell systemReview article: the treatment of acute biliary pancreatitis.Anaphylaxis induced by gabexate mesylate.N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.Hereditary pancreatitis and mutations of the cationic trypsinogen gene.The ryanodine receptor mediates early zymogen activation in pancreatitis.Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.Pancreatitis after endoscopic retrograde cholangio-pancreatography.Prevention effect of allopurinol on post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of prospective randomized controlled trials.Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.Outcome of endotherapy for pancreas divisum in patients with acute recurrent pancreatitisPreventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?Acute pancreatitis--the current status in management.Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.Use of gabexate mesylate in Italian hospitals: a multicentre observational study.Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trialAntioxidant drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: What does evidence suggest?Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials.The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitisII. The Endocrine and Pancreatic Unit at the University of Verona, Italy.Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial.Pharmacological prevention and treatment of acute pancreatitis: where are we now?Post-ERCP pancreatitis and its prevention.Pancreatic sphincterotomy: technique, indications, and complications.Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography.Pharmacological approach to acute pancreatitis.Intracellular trypsin induces pancreatic acinar cell death but not NF-kappaB activation.Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitisCholedochoscope manometry about different drugs on the Sphincter of Oddi.JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitisDifferential roles of inflammatory cells in pancreatitis.
P2860
Q24235717-839F4A8D-DAFE-4F0F-A6DD-ECE4E6CA34D3Q24670166-E0564D56-7AC6-42ED-8E20-C21AB02EADDDQ31919311-56C6D402-8D18-46DF-8A41-B8BBB940FFCFQ33273455-8A4A9DC0-0FBB-4A20-82D9-72F1D49297CBQ33276374-66F9432C-B887-47F0-A95F-13A7CDC1095BQ33319646-0A734B02-48D9-4FBA-8D8A-AE0BDADD6319Q33634045-09139160-0C4C-4A20-9413-5E86A42C08E8Q33696361-1B96F863-4922-4E6D-B7C1-69C25F0F5278Q33696381-339D24ED-5440-4677-B84A-727995DEC03EQ33778802-312C45E2-DF46-49B2-995A-73432E6E8A5DQ33864840-60A4C691-4EB3-496C-88CF-CB363E3801F9Q33866411-E9EF613F-3403-4478-A3D2-45A96490FBDDQ33992750-39101CDF-27F7-4DB0-9E20-E862FCA899D0Q34063467-3DCFBBD4-D31C-4636-976A-A0719E3E2055Q34098709-EE958719-E120-4492-8AAA-9FA2E71906C1Q34100027-26C84378-D31C-4444-BD41-412144B72FE8Q34156180-179F69F4-D19D-4A9D-89A6-C510E5E8569BQ34390035-17A53999-5C46-438C-B852-5255600D7A29Q34696750-8C37636F-3C4C-4335-AC38-BB7BC88B818CQ35012013-27535CC0-0582-48DD-AD65-2B40FB3C5596Q35058128-7F596CF3-C209-4FE8-B941-C8245CFD31D1Q35137859-B320586C-1D92-458D-919C-6E5E85B37A61Q35149427-3DE36DE8-C746-42AB-B959-053EAC3E2635Q35596196-D00F95D7-82D0-4C62-AE43-4129820F24C5Q35692361-FF27291C-188D-4C80-ABB3-D683C0CB4D46Q35861545-4D95D7B7-076D-408A-ABDF-BCC417883343Q35931242-8555C4B6-DA76-474A-9800-0127F544B1F8Q36063135-0D35CA58-81A4-4A4B-A871-125821F0C89EQ36177978-2F88DD26-B095-437F-89F1-25FA811EC0D6Q36424901-B58017F8-497D-460D-A67B-CCA1135A32F3Q36478116-18534617-EEEA-4411-B114-DD271591D1D9Q36666312-029ABC90-4E89-49C7-8E79-4DE5F94874E0Q36909072-C86CCC85-A235-4430-AA2C-4953C51F6889Q37160556-65845D80-F71F-49BC-AC17-EB0133030C3EQ37169329-D89A8BAD-B673-4E6F-ABCE-E22D0536751CQ37285222-100D58CB-17EB-42F9-B7A6-BC2E5CE07842Q37318552-03B67C81-0F4E-4987-9731-33785A6D9606Q37362716-C3EAA476-0848-41B4-89BE-5C183BCD67BFQ37425938-C4EFAF3E-7C58-43EC-B44E-1A30EFB057C9Q37982806-FEAE7191-A73B-4411-969C-B69712497C76
P2860
Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@ast
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@en
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@nl
type
label
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@ast
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@en
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@nl
prefLabel
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@ast
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@en
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@nl
P2093
P1476
Gabexate for the prevention of ...... stive endoscopy--Italian Group
@en
P2093
A Tittobello
G Cavallini
L Frulloni
V Di Francesco
P304
P356
10.1056/NEJM199609263351302
P407
P577
1996-09-26T00:00:00Z